Kannu Bansal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kannu Bansal has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Dhaval Kolte
Harvard Medical School
4 shared publications - Saraschandra Vallabhajosyula
Division of Cardiology, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
4 shared publications Fahad Gilani
Division of Cardiovascular Medicine, Catholic Medical Center, Manchester, New Hampshire, USA
3 shared publications- Nihar R. Desai
Yale School of Medicine
3 shared publications Ralph J. Riello
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT (R.J.R., M.A.F., K.A.A.C., K.F.F., N.R.D.).
3 shared publications- Shubhadarshini Pawar
Karsh Center for Interventional Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
3 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (11)
H-1B Visa-Supported Cardiology Positions in the United States
- 18 November 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (11)
Open AccessH-1B Visa-Supported Cardiology Positions in the United States
- 4 August 2026
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (9)
Patient-Facing Alerts in Heart Failure
- 4 August 2026
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (9)
Patient-Facing Alerts in Heart Failure
- 9 May 2026
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (7) , 103100
Association Between Hospital Tier and Cardiogenic Shock Outcomes in the United States
- 9 May 2026
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (7) , 103100
Association Between Hospital Tier and Cardiogenic Shock Outcomes in the United States
- 29 August 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 13 (10) , 102620
Sex-Specific Transfer Outcomes in Patients With Non–Acute Myocardial Infarction-Related Cardiogenic Shock
- 29 August 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 13 (10) , 102620
Sex-Specific Transfer Outcomes in Patients With Non–Acute Myocardial Infarction-Related Cardiogenic Shock
- 1 April 2025
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (4) , e012477
Transfer to Hub Hospitals and Outcomes in Cardiogenic Shock
BACKGROUND: There are limited large-scale data on the outcomes of patients with cardiogenic shock (CS) transferred to hub centers. This study aimed to compare the characteristics and outcomes of transferred patients with CS versus those who were not transferred. METHODS: Adults (aged ≥18 years) with a primary or secondary diagnosis of CS were identified from the Nationwide Readmissions Database (2016–2020) and stratified by transfer status. Overlap propensity score weighting was performed to assess the association between transfer status and in-hospital mortality. Secondary outcomes, including length of hospital stay, hospitalization costs, and readmissions for cardiac and noncardiac etiologies, were assessed using multivariable regression. RESULTS: Of 314 098 patients with CS (27% with acute myocardial infarction-related CS and 73% with nonacute myocardial infarction-related CS), 30 630 (9.8%) were transferred. In the unweighted population, compared with nontransferred patients, transferred patients were on average younger (65 versus 68 years), had higher comorbidities, and were more likely to be cared for at large teaching hospitals. During the hospitalization, they had higher rates of renal failure, pulmonary artery catheter use, and mechanical circulatory support use. In-hospital mortality was lower in transferred patients—39.1% versus 47.1%; unadjusted odds ratio (OR), 0.71 (95% CI, 0.70–0.73); adjusted OR, 0.73 ([95% CI, 0.71–0.76]; P <0.001). This was consistent across subgroups of CS cause, age, sex, hospital location, mechanical circulatory support use, and presence of cardiac arrest. The transferred cohort had lower costs and length of stay, but more frequent all-cause (adjusted OR, 1.21 [95% CI, 1.16–1.27]), cardiac (adjusted OR, 1.16 [95% CI, 1.11–1.22]), heart failure (adjusted OR, 1.14 [95% CI, 1.08–1.21]), and noncardiac readmissions (adjusted OR, 1.68 [95% CI, 1.21–2.33]) at 30 days postdischarge compared with the nontransferred cohort. CONCLUSIONS: Despite higher comorbidity, organ failure, and use of cardiac/noncardiac procedures, patients with CS who were transferred to hub centers had lower in-hospital mortality, hospitalization costs, and length of stay.
- 1 April 2025
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (4) , e012477
Transfer to Hub Hospitals and Outcomes in Cardiogenic Shock
BACKGROUND: There are limited large-scale data on the outcomes of patients with cardiogenic shock (CS) transferred to hub centers. This study aimed to compare the characteristics and outcomes of transferred patients with CS versus those who were not transferred. METHODS: Adults (aged ≥18 years) with a primary or secondary diagnosis of CS were identified from the Nationwide Readmissions Database (2016–2020) and stratified by transfer status. Overlap propensity score weighting was performed to assess the association between transfer status and in-hospital mortality. Secondary outcomes, including length of hospital stay, hospitalization costs, and readmissions for cardiac and noncardiac etiologies, were assessed using multivariable regression. RESULTS: Of 314 098 patients with CS (27% with acute myocardial infarction-related CS and 73% with nonacute myocardial infarction-related CS), 30 630 (9.8%) were transferred. In the unweighted population, compared with nontransferred patients, transferred patients were on average younger (65 versus 68 years), had higher comorbidities, and were more likely to be cared for at large teaching hospitals. During the hospitalization, they had higher rates of renal failure, pulmonary artery catheter use, and mechanical circulatory support use. In-hospital mortality was lower in transferred patients—39.1% versus 47.1%; unadjusted odds ratio (OR), 0.71 (95% CI, 0.70–0.73); adjusted OR, 0.73 ([95% CI, 0.71–0.76]; P <0.001). This was consistent across subgroups of CS cause, age, sex, hospital location, mechanical circulatory support use, and presence of cardiac arrest. The transferred cohort had lower costs and length of stay, but more frequent all-cause (adjusted OR, 1.21 [95% CI, 1.16–1.27]), cardiac (adjusted OR, 1.16 [95% CI, 1.11–1.22]), heart failure (adjusted OR, 1.14 [95% CI, 1.08–1.21]), and noncardiac readmissions (adjusted OR, 1.68 [95% CI, 1.21–2.33]) at 30 days postdischarge compared with the nontransferred cohort. CONCLUSIONS: Despite higher comorbidity, organ failure, and use of cardiac/noncardiac procedures, patients with CS who were transferred to hub centers had lower in-hospital mortality, hospitalization costs, and length of stay.
- 25 February 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (7) , 882-894
Out-of-Hospital 30-Day Mortality After Mitral TEER
- 25 February 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (7) , 882-894
Out-of-Hospital 30-Day Mortality After Mitral TEER
- 1 February 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 18 (2) , e011331
Medicare Coverage and Patient Out-of-Pocket Costs for Mavacamten
- 1 February 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 18 (2) , e011331
Medicare Coverage and Patient Out-of-Pocket Costs for Mavacamten
- Open Access
- 11 September 2024
- Published by Radcliffe Medical Media Ltd in US Cardiology Review
- Vol. 18, e15
Apical Hypertrophic Cardiomyopathy in Middle-aged Male with Chest Pain
Learn more about apical hypertrophic cardiomyopathy in this free article from USC Journal. Apical Hypertrophic Cardiomyopathy in Middle-aged Male with Chest Pain.
- 11 September 2024
- Published by Radcliffe Medical Media Ltd in US Cardiology Review
- Vol. 18, e15
Open AccessApical Hypertrophic Cardiomyopathy in Middle-aged Male with Chest Pain
Learn more about apical hypertrophic cardiomyopathy in this free article from USC Journal. Apical Hypertrophic Cardiomyopathy in Middle-aged Male with Chest Pain.
- 4 September 2024
- Published by Elsevier in JACC: Heart Failure
- Vol. 12 (12) , 2087-2097
Impact of Inpatient Percutaneous Coronary Intervention Volume on 30-Day Readmissions After Acute Myocardial Infarction-Cardiogenic Shock
- 4 September 2024
- Published by Elsevier in JACC: Heart Failure
- Vol. 12 (12) , 2087-2097
Impact of Inpatient Percutaneous Coronary Intervention Volume on 30-Day Readmissions After Acute Myocardial Infarction-Cardiogenic Shock